Cite Filings / IOVA
Feed Companies Filings Check
Sign in

CIK 0001425205 · Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
753254381
Phone
6502607120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Filings Insiders Search text
All 1,050 Financials 345 Shareholder Meetings 19 Executive Compensation 299 Insider Trading 352 Beneficial Ownership Interest 125 Business Combinations 264 Public Offerings 101 Mutual Funds and ETFs 14 Others 122
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-04-28
  3. DEF 14A Proxy Proxy Statement 2025-04-28
  4. DEF 14A Proxy Proxy Statement 2024-04-29
  5. DEF 14A Proxy Proxy Statement 2023-04-26
  6. DEF 14A Proxy Proxy Statement 2022-04-27
  7. DEF 14A Proxy Proxy Statement 2021-04-27
  8. DEF 14A Proxy Proxy Statement 2020-04-27
  9. DEF 14A Proxy Proxy Statement 2019-04-29
  10. DEF 14A Proxy Proxy Statement 2018-04-25
  11. DEF 14A Proxy Proxy Statement 2017-04-20
  12. DEF 14A Proxy Proxy Statement 2016-07-07
  13. DEF 14A Proxy Proxy Statement 2016-04-28
  14. DEF 14A Proxy Proxy Statement 2015-04-30
  15. DEF 14A Proxy Proxy Statement 2014-09-23

Page 1 of 1 · 14 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…